Peter Verdult

Item: Peter Verdult
Rating: 0.41
Author: StockAnalysis.com

Stock Analyst at Citigroup

(0.41)

# 4,242

Out of 5,116 analysts

Total ratings

33.33%

Success rate

-14.96%

Average return

Main Sectors:

Top Industries:

Stocks Rated by Peter Verdult

Stock	Action	Price Target	Current	Upside	Ratings	Updated
LLY Eli Lilly and Company	Maintains: Buy	$1,250 → $1,500	$1,037.15	+44.63%	4	Nov 12, 2025
EVO Evotec SE	Upgrades: Buy	n/a	$3.67	-	1	Jun 8, 2023
GLPG Galapagos NV	Upgrades: Buy	n/a	$33.88	-	1	Jan 27, 2022

Eli Lilly and Company

Nov 12, 2025

Maintains: Buy

Price Target: $1,250 → $1,500

Current: $1,037.15

Upside: +44.63%

Evotec SE

Jun 8, 2023

Upgrades: Buy

Price Target: n/a

Current: $3.67

Upside: -

Galapagos NV

Jan 27, 2022

Upgrades: Buy

Price Target: n/a

Current: $33.88

Upside: -